Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-038551
Filing Date
2020-08-10
Accepted
2020-08-10 06:05:53
Documents
61
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q pstv-10q_20200630.htm 10-Q 1859706
2 EX-31.1 pstv-ex311_6.htm EX-31.1 16485
3 EX-31.2 pstv-ex312_8.htm EX-31.2 16123
4 EX-32.1 pstv-ex321_7.htm EX-32.1 11678
  Complete submission text file 0001564590-20-038551.txt   5914828

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT pstv-20200630.xml EX-101.INS 1032354
6 XBRL TAXONOMY EXTENSION SCHEMA pstv-20200630.xsd EX-101.SCH 51293
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pstv-20200630_cal.xml EX-101.CAL 61635
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pstv-20200630_def.xml EX-101.DEF 151417
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE pstv-20200630_lab.xml EX-101.LAB 398438
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pstv-20200630_pre.xml EX-101.PRE 304665
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Filer) CIK: 0001095981 (see all company filings)

EIN.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34375 | Film No.: 201086918
SIC: 3841 Surgical & Medical Instruments & Apparatus